BBC0403
BBC0403 is a selective BRD2 inhibitor with Kds of 7.64 μM and 41.37 μM for BRD2 (BD2) and BRD2 (BD1), respectively. BBC0403 exhibitS higher binding specificity for BRD2 compared to BRD3 and BRD4. BBC0403 has the potential for osteoarthritis (OA) research[1].
Product Specifications
CAS Number
[2644662-83-7]
UNSPSC
12352005
Target
Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Epigenetics
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/bbc0403.html
Purity
98.78
Solubility
DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C1NC(C2=CC(C)=C(OC3COC3)C(C)=C2)=NC4=C1C(OC)=CC(OC)=C4
Molecular Formula
C21H22N2O5
Molecular Weight
382.41
References & Citations
[1]Hyemi Lee, et al. BRD2-specific inhibitor, BBC0403, inhibits the progression of osteoarthritis pathogenesis in osteoarthritis-induced C57BL/6 male mice. Br J Pharmacol. 2024 Apr 10.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
BRD2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15137767 1 Vial
Lentiviral human ABCA13 shRNA (UAS) - Lentiviral human ABCA13 shRNA (UAS) plasmid
Ask
View Details 
MBS1396549-01 0.02 mg (E-Coli)
Recombinant Acinetobacter sp. Pantothenate synthetase (panC)
Ask
View Details MBS1396549-02 0.02 mg (Yeast)
Recombinant Acinetobacter sp. Pantothenate synthetase (panC)
Ask
View Details MBS1396549-03 0.1 mg (E-Coli)
Recombinant Acinetobacter sp. Pantothenate synthetase (panC)
Ask
View Details